Skip Navigation

European Heart Journal 2002 23(11):845-848; doi:10.1053/euhj.2001.3131
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Raj, S.R.
Right arrow Articles by Wyse, D.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raj, S.R.
Right arrow Articles by Wyse, D.G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Rhythm control for paroxysmal atrial fibrillation after AV junction ablation: is it worth the effort?

S.R. Raj and D.G. Wyse

Cardiovascular Research Group, University of Calgary, Calgary, Alberta, Canada

References

  1. Wolf PA, Dawber TR, Thomas HEJ, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973–977[Abstract/Free Full Text]
  2. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998;32:695–703[Abstract/Free Full Text]
  3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952[Abstract/Free Full Text]
  4. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation. 1998;98:2574–2579[Abstract/Free Full Text]
  5. Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy. Circulation. 2001;104:292–296[Abstract/Free Full Text]
  6. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000;356:1789–1794[CrossRef][ISI][Medline]
  7. Wyse DG. The AFFIRM trial: main trial and substudies— what can we expect? J Interv Card Electrophysiol. 2000;4:171–176
  8. DiMarco JP. Mortality and stroke rates in a trial of rhythm control versus rate control in atrial fibrillation. Results from the STAF Pilot Phase (Strategies of Treatment of Atrial Fibrillation) (Abstr). J Am Coll Cardiol. 2001;38:603
  9. Vora AM, Goyal VS, Naik AM. Maintenance of sinus rhythm by amiodarone is superior to ventricular rate control in rheumatic atrial fibrillation: A blinded placebo-controlled study (Abstr). PACE. 2001;24:546
  10. Hagens VE, Kingma T, Ike R. Rate control versus electrical cardioversion for persistent atrial fibrillation: baseline characteristics of the RACE study (Abstr). Eur Heart J. 2001;22:S190
  11. Brignole M, Gianfranchi L, Menozzi C. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation. 1997;96:2617–2624[Abstract/Free Full Text]
  12. Brignole M, Menozzi C, Gianfranchi L. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation. 1998;98:953–960[Abstract/Free Full Text]
  13. Gillis AM, Connolly SJ, Lacombe P. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. Circulation. 2000;102:736–741[Abstract/Free Full Text]
  14. Gianfranchi L, Brignole M, Menozzi C, Lolli G, Bottoni N. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias. Am J Cardiol. 1998;81:351–354[CrossRef][ISI][Medline]
  15. Brignole M, Menozzi C, Gasparini M. An evaluation of the strategy of maintainance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J. 2002;23:892–900[Abstract/Free Full Text]
  16. Skanes AC, Krahn AD, Yee R. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol. 2001;38:167–172[Abstract/Free Full Text]
  17. Nacarelli GV. The Dual-Site Atrial Pacing for the Prevention of Atrial Fibrillation (DAPPAF) Trial: improved suppression of recurrent atrial fibrillation with dual-site atrial pacing and antiarrhythmic drug therapy (Abstr). J Am Coll Cardiol. 2001;38:598[CrossRef]
  18. Gillis AM, Wyse DH, Connolly SJ. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation. 1999;99:2553–2558[Abstract/Free Full Text]
  19. Friedman PA, Dijkman B, Warman EN. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation. 2001;104:1023–1028[Abstract/Free Full Text]
  20. Adler SW, Wolpert C, Warman EN, Musley SK, Koehler JL, Euler DE. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation. 2001;104:887–892[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Raj, S.R.
Right arrow Articles by Wyse, D.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raj, S.R.
Right arrow Articles by Wyse, D.G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?